Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
Crossref DOI link: https://doi.org/10.1186/s12885-016-2828-6
Published Online: 2016-10-10
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Propper, David
Jones, Keith
Anthoney, D. Alan
Mansoor, Wasat
Ford, Daniel
Eatock, Martin
Agarwal, Roshan
Inatani, Michiyasu
Saito, Tomohisa
Abe, Masaichi
Evans, T. R. Jeffry